Dr Ines Rombach
School of Medicine and Population Health
Senior Research Fellow/ Statistician
+44 114 222 0840
Full contact details
School of Medicine and Population Health
Barber House
Sheffield
S10 2HQ
- Profile
-
As a statistician within the CTRU in ScHARR, I am involved in all aspects of clinical trials. I contribute statistical expertise to the development of grant applications and to the planning, conduct, analysis and reporting of randomised controlled trials.
I have experience of working on trials in orthopaedics, surgery, and complex interventions.
- Research interests
-
My research interests include the handling and reporting of missing data in randomised clinical trials, the use of patient reported outcomes and surgical trials methodology.
- Publications
-
Journal articles
- . Annals of the Rheumatic Diseases, 84, 401-402.
- . Efficacy and Mechanism Evaluation.
- . Rheumatology, 64(Supplement_3).
- . Journal of Arthroscopy and Joint Surgery, 12(2), 68-79.
- . British Journal of Sports Medicine, 59(2), 109-117.
- . Transplantation, 108(11), 2278-2286.
- . British Journal of Anaesthesia, 133(4), 862-873.
- . Orthopaedic Proceedings, 106-B(SUPP_15), 37-37.
- . Bone & Joint Open, 5(7), 612-620.
- . European Journal of Nuclear Medicine and Molecular Imaging, 51(10), 3009-3025.
- . Therapeutic Advances in Musculoskeletal Disease, 16.
- . Diabetic Medicine, 41(9).
- . Orthopaedic Proceedings, 106-B(SUPP_6), 46-46.
- . Trials, 25(1).
- . Pilot and Feasibility Studies, 10.
- . The Lancet Rheumatology, 6(2), e92-e104.
- . Wellcome Open Research, 8.
- . Bone & Joint Open, 3(11), 898-906.
- . The Lancet Respiratory Medicine, 10(9), 840-850.
- . Journal of the American Medical Association, 327(19), 1875-1887.
- . BMJ Open, 12(5).
- . The Lancet Rheumatology, 4(6), E407-E416.
- . BMJ Open, 12(4).
- . BMJ Open, 12(4).
- . JAMA Surgery, 157(6), 481-489.
- . BJU International, 130(1), 43-53.
- . Therapeutic Advances in Musculoskeletal Disease, 14.
- . Osteoarthritis and Cartilage Open, 3(3).
- . The Lancet Global Health, 9(8), e1163-e1168.
- . Trials, 22(1).
- . Trials, 22.
- . Rheumatology, 60(6), 2862-2877.
- . Quality of Life Research, 30(3), 867-879.
- . BMC Medicine, 18.
- . Rheumatology, 59(Supplement_2).
- . Rheumatology, 59(Supplement_2).
- . Wellcome Open Research, 4.
- . The Bone & Joint Journal, 102-B(1), 48-54.
- . The Lancet Infectious Diseases, 19(10), 1058-1058.
- . Health Technology Assessment, 23(38).
- . BMJ: British Medical Journal, 364.
- . New England Journal of Medicine, 380(5), 425-436.
- . Bone and Joint Journal, 101-B(1), 55-62.
- . Journal of Clinical Epidemiology, 106, 108-120.
- . BMC Medical Research Methodology, 18(1).
- . BMC Medical Research Methodology, 18(1).
- . Journal of Clinical Epidemiology, 99, 75-83.
- . Patient Related Outcome Measures, 9, 197-209.
- . The Lancet, 391(10118), 329-338.
- . Osteoarthritis and Cartilage, 25(9), 1468-1477.
- . Pilot and Feasibility Studies, 3(1).
- . Trials, 17.
- . BMC Medicine, 14.
- . The Bone & Joint Journal, 98-B(10_Supple_B), 22-27.
- . Journal of Hip Preservation Surgery, 3(suppl_1).
- . BMJ Open, 6(3), e010194-e010194.
- . Quality of Life Research, 25(7), 1613-1623.
- . Trials, 16(1).
- . Trials, 16(S2).
- . Trials, 16(S2).
- . The American Journal of Sports Medicine, 43(12), 2891-2897.
- . Trials, 16(1).
- . Bone & Joint Research, 3(11), 321-327.
- . British Journal of Sports Medicine, 48(15), 1198-1198.
- . BMJ, 348(may21 2), g3253-g3253.
- . Seminars in Arthritis and Rheumatism, 43(4), 570-576.
- . BMJ, 347(dec19 2), f6956-f6956.
- . Trials, 14(S1).
- . Trials, 14(S1).
- . Trials, 14(S1).
- . Trials, 14(S1).
- . Trials, 14(1).
- . The Breast, 22(5), 850-855.
- . Bone & Joint Research, 2(2), 33-40.
- . Trials, 12(S1).
- . Bone & Joint Open, 6(5), 506-516.
- . Bone & Joint Open, 6(5), 517-527.
- . Efficacy and Mechanism Evaluation, 12(05), 45-46.
- . Efficacy and Mechanism Evaluation, 12(05), 47-48.
- . Efficacy and Mechanism Evaluation, 12(05), 43-44.
- . Bone & Joint Open, 5(7), 534-542.
- . Health Technology Assessment, 26(43), 1-58.
- . Communications Medicine, 1(1).
- . Wellcome Open Research, 4, 108-108.
- . Wellcome Open Research, 4, 108-108.
- . Wellcome Open Research, 4, 108-108.
Conference proceedings
- Two-week Break in Methotrexate Treatment and COVID-19 Vaccine Response. Results of the Vaccine Response on off Methotrexate (VROOM) Study, an Open Label, Prospective, Two-arm Parallel-group, Multi-center, Superiority, Randomized Controlled Trial. ARTHRITIS & RHEUMATOLOGY, Vol. 75 (pp 3331-3333)
- . Health and Quality of Life Outcomes, Vol. 15(Supplement 1). England
- . Health and Quality of Life Outcomes, Vol. 14(S1). Sheffield, UK, 9 June 2016 - 9 June 2016.
- . Abstracts (pp A22.2-A23)
Other
- . New England Journal of Medicine, 381(12), 1182-1184.
Preprints
- , Cold Spring Harbor Laboratory.
- , Springer Science and Business Media LLC.
- , Springer Science and Business Media LLC.
- Professional activities and memberships
-
I am involved in Data Monitoring and Safety Committees as the independent statistician and regularly teach a variety of topics, including aspects of clinical trial design, and statistical concepts.